首页> 外文期刊>Trials >The citation of relevant systematic reviews and randomised trials in published reports of trial protocols
【24h】

The citation of relevant systematic reviews and randomised trials in published reports of trial protocols

机译:在试验方案的公开报告中引用相关的系统评价和随机试验

获取原文
获取外文期刊封面目录资料

摘要

Background It is important that planned randomised trials are justified and placed in the context of the available evidence. The SPIRIT guidelines for reporting clinical trial protocols recommend that a recent and relevant systematic review should be included. The aim of this study was to assess the use of the existing evidence in order to justify trial?conduct. Methods Protocols of randomised trials published over a 1-month period (December 2015) indexed in PubMed were obtained. Data on trial characteristics relating to location, design, funding, conflict of interest and type of evidence included for trial justification was extracted in duplicate and independently by two investigators. The frequency of citation of previous research including relevant systematic reviews and randomised trials was assessed. Results Overall, 101 protocols for RCTs were identified. Most proposed trials were parallel-group ( n =?74; 73.3%). Reference to an earlier systematic review with additional randomised trials was found in 9.9% ( n =?10) of protocols and without additional trials in 30.7% ( n =?31), while reference was made to randomised trials in isolation in 21.8% ( n =?22). Explicit justification for the proposed randomised trial on the basis of being the first to address the research question was made in 17.8% ( n =?18) of protocols. A randomised controlled trial was not cited in 10.9% (95% CI: 5.6, 18.7) ( n =?11), while in 8.9% (95% CI: 4.2, 16.2) ( n =?9) of the protocols a systematic review was cited but did not inform trial design. Conclusions A relatively high percentage of protocols of randomised trials involves prior citation of randomised trials, systematic reviews or both. However, improvements are required to ensure that it is explicit that clinical trials are justified and shaped by contemporary best evidence.
机译:背景技术计划随机试验的合理性并置于可用证据的背景下,这一点很重要。 SPIRIT报告临床试验方案的指南建议应包括近期和相关的系统评价。这项研究的目的是评估现有证据的使用,以证明审判的合理性。方法获得在PubMed上索引的为期1个月(2015年12月)发表的随机试验方案。由两名调查员一式两份地独立提取了与审判地点,设计,资金,利益冲突和证据类型有关的审判特征数据,以供进行审判辩护。评估了包括相关系统评价和随机试验在内的先前研究的被引频次。结果总体上,确定了101个RCT方案。大多数提议的试验为平行组(n =?74; 73.3%)。在9.9%(n =?10)的研究方案中发现有较早的系统评价和其他随机试验,而在30.7%(n =?31)的试验中未进行其他试验,而在单独的试验中则有21.8%(n n =?22)。在第一个解决研究问题的基础上,对拟议的随机试验的明确论证是在17.8%(n =?18)的方案中进行的。方案的10.9%(95%CI:5.6,18.7)(n =?11)未引用随机对照试验,而8.9%(95%CI:4.2,16.2)(n =?9)评论被引用,但没有告知试验设计。结论相对较高比例的随机试验方案涉及事先引用随机试验,系统评价或两者兼而有之。但是,需要进行改进以确保明确证明临床试验是由当代最佳证据证明是正确的并具有一定的影响力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号